110 related articles for article (PubMed ID: 35641278)
21. Right Ventricular Function in Peripartum Cardiomyopathy at Presentation Is Associated With Subsequent Left Ventricular Recovery and Clinical Outcomes.
Blauwet LA; Delgado-Montero A; Ryo K; Marek JJ; Alharethi R; Mather PJ; Modi K; Sheppard R; Thohan V; Pisarcik J; McNamara DM; Gorcsan J;
Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166247
[TBL] [Abstract][Full Text] [Related]
22. Detection of early sub-clinical trastuzumab-induced cardiotoxicity in breast cancer patients.
Dores H; Abecasis J; Correia MJ; Gândara F; Fonseca C; Azevedo J; Arroja I; Martins A; Mendes M
Arq Bras Cardiol; 2013 Apr; 100(4):328-32. PubMed ID: 23525273
[TBL] [Abstract][Full Text] [Related]
23. [Clinical characteristics of heart failure with recovered ejection fraction].
Luo Y; Chai K; Cheng YL; Zhu WR; Li YY; Wang H; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):333-339. PubMed ID: 33874682
[No Abstract] [Full Text] [Related]
24. Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of ERBB2-Positive Breast Cancer.
Yu AF; Flynn JR; Moskowitz CS; Scott JM; Oeffinger KC; Dang CT; Liu JE; Jones LW; Steingart RM
JAMA Cardiol; 2020 Mar; 5(3):309-317. PubMed ID: 31939997
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction.
Citro R; Radano I; Parodi G; Di Vece D; Zito C; Novo G; Provenza G; Bellino M; Prota C; Silverio A; Antonini-Canterin F; Rigo F; Vriz O; Galasso G; Bossone E; Salerno-Uriarte J; Piscione F
Eur J Heart Fail; 2019 Jun; 21(6):781-789. PubMed ID: 30714660
[TBL] [Abstract][Full Text] [Related]
26. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction.
Fei HW; Ali MT; Tan TC; Cheng KH; Salama L; Hua L; Zeng X; Halpern EF; Taghian A; MacDonald SM; Scherrer-Crosbie M
Echocardiography; 2016 Apr; 33(4):519-26. PubMed ID: 26992012
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction.
Houard L; Amzulescu MS; Colin G; Langet H; Militaru S; Rousseau MF; Ahn SA; Vanoverschelde JJ; Pouleur AC; Gerber BL
Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011680. PubMed ID: 33438438
[TBL] [Abstract][Full Text] [Related]
28. Comparison of left ventricular longitudinal systolic function parameters in the prediction of adverse outcome in heart failure with preserved ejection fraction.
Gozdzik A; Marwick TH; Przewlocka-Kosmala M; Jankowska EA; Ponikowski P; Kosmala W
ESC Heart Fail; 2021 Apr; 8(2):1531-1540. PubMed ID: 33570238
[TBL] [Abstract][Full Text] [Related]
29. Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity.
Pituskin E; Mackey JR; Koshman S; Jassal D; Pitz M; Haykowsky MJ; Pagano JJ; Chow K; Thompson RB; Vos LJ; Ghosh S; Oudit GY; Ezekowitz JA; Paterson DI
J Clin Oncol; 2017 Mar; 35(8):870-877. PubMed ID: 27893331
[TBL] [Abstract][Full Text] [Related]
30. Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes.
Albert J; Lezius S; Störk S; Morbach C; Güder G; Frantz S; Wegscheider K; Ertl G; Angermann CE
J Am Heart Assoc; 2021 Feb; 10(3):e017822. PubMed ID: 33496189
[TBL] [Abstract][Full Text] [Related]
31. Left ventricular global longitudinal strain predicts major adverse cardiac events and all-cause mortality in heart transplant patients.
Clemmensen TS; Eiskjær H; Løgstrup BB; Ilkjær LB; Poulsen SH
J Heart Lung Transplant; 2017 May; 36(5):567-576. PubMed ID: 28089194
[TBL] [Abstract][Full Text] [Related]
32. Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer.
Battisti NML; Andres MS; Lee KA; Ramalingam S; Nash T; Mappouridou S; Senthivel N; Asavisanu K; Obeid M; Tripodaki ES; Angelis V; Fleming E; Goode EF; John S; Rosen SD; Allen M; Stanway S; Lyon AR; Ring A
Breast Cancer Res Treat; 2021 Jul; 188(1):149-163. PubMed ID: 33818652
[TBL] [Abstract][Full Text] [Related]
33. Cardiotoxicity evaluation using magnetic resonance imaging in breast Cancer patients (CareBest): study protocol for a prospective trial.
Hong YJ; Kim GM; Han K; Kim PK; Lee SA; An E; Lee JY; Lee HJ; Hur J; Kim YJ; Kim MJ; Choi BW
BMC Cardiovasc Disord; 2020 Jun; 20(1):264. PubMed ID: 32493217
[TBL] [Abstract][Full Text] [Related]
34. Early Decline in Left Ventricular Ejection Fraction Can Predict Trastuzumab-Related Cardiotoxicity in Patients with Breast Cancer: A Study Using 13 Years of Registry Data.
Kim EK; Cho J; Kim JY; Chang SA; Park SJ; Choi JO; Lee SC; Ahn JS; Park SW; Im YH; Jeon ES; Park YH
Cancer Res Treat; 2019 Apr; 51(2):727-736. PubMed ID: 30177584
[TBL] [Abstract][Full Text] [Related]
35. A Prospective Study About Trastuzumab-induced Cardiotoxicity in HER2-positive Breast Cancer.
Ben Kridis W; Sghaier S; Charfeddine S; Toumi N; Daoud J; Kammoun S; Khanfir A
Am J Clin Oncol; 2020 Jul; 43(7):510-516. PubMed ID: 32304433
[TBL] [Abstract][Full Text] [Related]
36. Impacts of non-recovery of trastuzumab-induced cardiomyopathy on clinical outcomes in patients with breast cancer.
Yoon HJ; Kim KH; Kim HY; Park H; Cho JY; Hong YJ; Park HW; Kim JH; Ahn Y; Jeong MH; Cho JG; Park JC
Clin Res Cardiol; 2019 Aug; 108(8):892-900. PubMed ID: 30737527
[TBL] [Abstract][Full Text] [Related]
37. Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab.
Tan TC; Bouras S; Sawaya H; Sebag IA; Cohen V; Picard MH; Passeri J; Kuter I; Scherrer-Crosbie M
J Am Soc Echocardiogr; 2015 May; 28(5):509-14. PubMed ID: 25772019
[TBL] [Abstract][Full Text] [Related]
38. Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced Cardiomyopathy.
Singh JP; Solomon SD; Fradley MG; Barac A; Kremer KA; Beck CA; Brown MW; McNitt S; Schleede S; Zareba W; Goldenberg I; Kutyifa V;
JAMA; 2019 Nov; 322(18):1799-1805. PubMed ID: 31714987
[TBL] [Abstract][Full Text] [Related]
39. Global longitudinal strain improves risk assessment after ST-segment elevation myocardial infarction: a comparative prognostic evaluation of left ventricular functional parameters.
Holzknecht M; Reindl M; Tiller C; Reinstadler SJ; Lechner I; Pamminger M; Schwaiger JP; Klug G; Bauer A; Metzler B; Mayr A
Clin Res Cardiol; 2021 Oct; 110(10):1599-1611. PubMed ID: 33884479
[TBL] [Abstract][Full Text] [Related]
40. Impact of β-blocker therapy on right ventricular function in heart failure patients with reduced ejection fraction. A prospective evaluation.
Galves R; Da Costa A; Pierrard R; Bayard G; Guichard JB; Isaaz K
Echocardiography; 2020 Sep; 37(9):1392-1398. PubMed ID: 32815195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
